The influence of TNF-α and Fas-ligand (FasL) on viability and function was evaluated in fresh-and expanded-umbilical cord blood (UCB) cells. CD34 + progenitors and T cells display outstanding survival, whereas~30% and >50% B lymphocytes and myeloid cells undergo spontaneous apoptosis within 24 and 48 h, respectively. Although the impact of exposure to toxic doses of FasL and TNF-α was undetectable in measurements of apoptosis; removal of dead cells after 2 days of incubation with the ligands revealed a twofold increase in frequency of colony-forming cells (CFU). The sensitivity of progenitors to apoptosis was also unaffected by Fas cross-linking following TNF-induced upregulation of the receptor, increasing CFU frequency without impairing SCID repopulating cell (SRC) activity. Most significant enrichment in CD34 + progenitors and corresponding increase in CFU frequency were observed when FasL was applied during the final week of ex vivo expansion under the influence of nicotinamide, without impairing SRC activity. These data emphasize differential sensitivities of UCB progenitors and lineage-positive cells to apoptotic signaling mediated by the Fas and TNF receptors, which might be useful in improving the efficiency of ex vivo expansion and improving UCB cell engraftment.
INTRODUCTION
Umbilical cord blood (UCB) is a rich source of hematopoietic progenitors with significant implementation in the treatment of malignant and nonmalignant disorders. [1] [2] [3] [4] [5] [6] The use of UCB for transplantation is limited by the insufficient cell numbers required to attain the threshold of adult recipients and the slow tempo of engraftment. [7] [8] [9] [10] Approaches to overcome the small cell numbers have been implemented with relative success, including transplantation of two or more UCB units 11, 12 and ex vivo expansion of progenitors. [13] [14] [15] The second limitation of UCB transplants is a relatively slow tempo of reconstitution, which is likely an intrinsic characteristic of circulating primitive progenitors inexperienced in interaction with the bone-marrow stroma. [2] [3] [4] [7] [8] [9] [10] In addition, although the incidence and intensity of GvHD are generally reduced in UCB cell transplants, this reaction might cause significant morbidity. 16 We have recently found that the TNF-family receptors have different functions in hematopoietic stem and progenitor cells and in the differentiated immuno-hematopoietic progeny. In contrast to apoptotic signaling in differentiated cells that mediates homeostatic negative regulation, murine and human precursors are inherently insensitive to apoptosis. [17] [18] [19] [20] Signaling mediated by the Fas, TNF and TNF-Related Apoptosis-Inducing Ligand (TRAIL) receptors triggers progenitor activity and synergizes with other inductive factors in promoting hematopoietic differentiation. 19, 21, 22 This mechanism links injury signals, including TNF-family ligands, with the activation of the hematopoietic system to ensure prompt recovery from hypoplasia. It also explains the marked upregulation of these receptors under conditions of stress hematopoiesis 23 and ubiquitous expression in most primitive progenitors. 17, 20, 21 The identified physiological roles of receptor/ligand interactions in the transplant setting include cell interaction with bone-marrow stroma 24 and autocrine-and paracrine-trophic signaling. [18] [19] [20] [21] [22] In addition to these early activities, hematopoietic progenitors deficient in Fas and TNF receptors fail to mediate durablemultilineage reconstitution. 17, 18 Insensitivity of hematopoietic progenitors to apoptosis can be used to improve the outcome of transplants, conferring immune privilege to the graft 24, 25 and fostering progenitor activity. [19] [20] [21] [22] A pretransplant apoptotic challenge with Fas-ligand (FasL) and TNF-α reduces significantly the incidence and severity of GvHD in haploidentical-and xenogeneic-murine transplants, 26, 27 and improves early myeloid reconstitution. 20, 22 In this study we assessed possible implementation of apoptotic signaling in several aspects of UCB cell transplantation. Following documentation of the insensitivity of UCB progenitors to apoptotic signaling, 20 we assessed the influence of FasL, TNF-α and their combination on the various lineages as a possible approach to graft preparation for transplantation. We reasoned that differential sensitivities of progenitors and differentiated cells to apoptotic signals may be used to improve the outcome of ex vivo expansion. We found that inclusion of FasL in the culture medium improves the efficiency of expansion without impairing progenitor activity. cells were diluted twofold with medium containing 0.5% human serum albumin and were isolated by centrifugation over a Ficoll-density gradient (1.077-1.08 g/mL, MP Biomedical, Illkirch, France). 19, 20 CD34 + progenitors were immunomagnetically isolated using the CD34 Progenitor Cell Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany).
Flow cytometry
Measurements were performed with a Vantage SE-2 flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). CD34 + cells were identified using antigen-presenting cells-labeled antibodies (clone 8G12, Pharmingen, San Diego, CA, USA) and lineages were quantified using phycoerythrin-labeled mAb: anti-human CD3 (clone OKT3, Pharmingen), anti-human CD19 (clone HD37, IQ Products, Groningen, Netherlands) and anti-human CD33 (clone WM53, IQ Products). 27 Expression of the receptors was determined using mAb against human Fas (clone DX2, Miltenyi Biotec), TNF-R1 and TNF-R2 (clones 16803 and 22235, respectively, R&D Systems, Abingdon, UK). 22 Cell death and apoptosis were determined in cells incubated with 5 μg/mL 7-aminoactinomycin-D (7-AAD, Sigma, St Louis, MO, USA) and Annexin-V (IQ Products), respectively. 17 Engraftment of UCB cells in NOD.SCID xenochimeras was determined in the bone marrow after 12 weeks using antibodies against murine CD45 (clone 30-F11, eBioscience, San Diego, CA, USA) and human CD45 (clone ML2, IQ Products). 19, 20, 22 Cell cycling was determined with an intracellular dye loaded by incubation for 7 min with 5 μM of (5-and 6-)carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR, USA). Proliferation index was quantified with the ModFit software (Verity Software House, Topsham, ME, USA).
Apoptotic challenge
Cell suspensions (5x10 6 cells/mL) were incubated for variable periods of time at 37°C in 5% CO 2 in a humidified incubator in medium, and with supplementation of either FLAG-tagged FasL (Axxora, Farmingdale, NY, USA) or 20 ng/mL recombinant TNF-α (PeproTech, Rocky Hill, NJ, USA). Human cells were incubated in minimum essential medium-α (α-MEM) culture medium (Biological Industries, Beit Haemek, Israel) supplemented with StemPro Nutrient Supplement (Stem Cell Technologies, Vancouver, BC, Canada), 2 mM L-glutamine and 50 mM 2β-Mercaptoethanol purchased from PeproTech. Dead cells were eliminated by centrifugation over a Ficoll gradient (MP Biomedical). fetal bovine serum, 50 ng/mL thrombopoietin, 50 ng/mL interleukin-6, 50 ng/mL fms-like tyrosine kinase-3 ligand and 50 ng/mL stem cell factor (PeproTech) with 5 mM nicotinamide (Sigma). 28 Cultures were incubated at 37°C in a humidified atmosphere of 5% CO 2 for 3 weeks, and were refreshed weekly with an equal volume of fresh medium.
Ex vivo expansion
Colony forming unit (CFU) assays and NOD.CB17-Prkdc scid (NOD.SCID, H2K g7 ) purchased from Jackson Laboratories (Bar Harbor, ME, USA) and housed in a barrier facility in accordance with the guidelines of the Institutional Animal Care and Use Committee. NOD SCID mice were conditioned with two consecutive daily doses of 25 μg/g BU (Sigma). 19, 20, 22 Levels of human chimerism were determined in the bone marrow and spleen after 12 weeks using specific human markers. Levels of xenochimerism vary widely in individual mice grafted with cells from the same sample, therefore this assay was used primarily to determine possible negative effect of the experimental procedures on SRC.
Statistical analysis
Data are presented as means six standard deviations for each experimental protocol. Results in each experimental group were evaluated for reproducibility by linear regression of duplicate measurements. Differences between the experimental protocols were estimated with a post-hoc Scheffe t-test and significance was considered at Po0.05.
RESULTS
Differential sensitivity of UCB subsets to receptor-mediated apoptosis Following the observation that hematopoietic progenitors derived from human UCB are resistant to receptor-mediated apoptosis, 20 we assessed the sensitivities of lineage-positive UCB subsets to these receptors. An apoptotic challenge was applied by supplementation of toxic doses of FasL and TNF-α to cells incubated without supporting or stimulating chemokines and measurements were performed by gating on various subsets in mixed-UCB suspensions. CD34
+ progenitors and CD3 + T cells presented remarkably low levels of fractional apoptosis, whereas the viability of CD19 + B lymphocytes and CD33 + myeloid cells decreased substantially when incubation was extended from 24 ( Figure 1a ) to 48 h (Figure 1b) . Remarkably, fractional apoptosis appears to be determined primarily by susceptibilities of the various UCB lineages to spontaneous apoptosis with insignificant impact of the death ligands. This profile questioned whether the various UCB lineages express the cognate receptors and are therefore responsive to the apoptotic signals. We found that the overall patterns of receptor expression were dissociated from sensitivity to spontaneous and receptor-induced apoptosis in all UCB lineages (Figure 1c ). On the one hand, Fas and both TNF receptors were equally expressed in~20% of fresh CD34 + progenitors, and Fas was expressed in~50% of T cells (Figure 1c ), exceeding by far the levels of fractional apoptosis observed in these subsets. In addition, the TNF receptors were expressed in 40-60% of the myeloid cells, which displayed progressive apoptosis in liquid culture. Thus expression of the receptor and its activation by the cognate ligand is not associated with obligatory-apoptotic signaling. On the other hand, the Fas and TNF receptors were expressed at low levels in on B lymphocytes (Figure 1c ), below the levels of fractional apoptosis displayed by this subset. Altogether these data demonstrate that UCB cell death is dominated by the susceptibility to spontaneous apoptosis, which exceeds the consequences of apoptotic receptor activation.
Next we assessed the cycling rates, as differential proliferation of viable subsets might affect the measurements of fractional apoptosis within heterogeneous cell populations. Assessment of the cycling rates after 48 h of incubation showed slow proliferation of CD34 + progenitors and CD33 + myeloid cells as compared with T and B cells (P o0.01, Figure 1d ), without evident variations induced by the presence of the apoptotic ligands. Thus, low levels and fractional apoptosis of CD3 + T cells were also affected by faster cycling rates, whereas the myeloid subset was most sensitive to spontaneous apoptosis and presented the slowest rates of proliferation.
TNF-α upregulates Fas expression without sensitizing to apoptosis Besides direct activity of TNF-α through its cognate receptors, this cytokine has been also shown to operate through induction of Fas expression. 29, 30 To evaluate this indirect mechanism, UCB cells were exposed to TNF-α and were sequentially submitted to an apoptotic challenge with FasL during the second day of culture (Figure 2a redundant activity. Progenitor death and dysfunction after extended culture for 72 h has long been recognized to decrease the number of colonies, irrespective of the presence of apoptotic signals. [31] [32] [33] Like TRAIL, 19 TNF-α had a mild-protective effect (nonsignificant) on UCB cells incubated for 72 h. Altogether these data demonstrate functional-negative selection of progenitors by induction of receptor-mediated apoptosis in sensitive cells, despite no apparent differences in viability in direct measurements of apoptosis (Figures 1a, b and 2c ).
Apoptotic signaling does no impair SRC activity The most significant prerequisite of expansion protocols is to maintain the activity of repopulating cells, which is best evaluated in a surrogate assay of SRC representing a more primitive subset of progenitors than CFU. 19 We have demonstrated that exposure to FasL 20 and TNF-α 22 for 48 h does not impair SRC activity, and subsequently assessed the impact of sequential exposure to both ligands. Transplantation of equal numbers of viable cells following sequential incubation with TNF-α and FasL into NOD.SCID mice showed comparable levels of xenochimerism as cells incubated with and without TNF-α alone (Figure 3b) . Furthermore, the bone marrow of NOD.SCID xenochimeras presented increased fractions of human B lymphocytes after 12 weeks, which is the dominant lineage developing from UCB progenitors (Figure 3c) . Altogether these data demonstrate that pretransplant TNF-mediated upregulation of Fas and cross-linking of this receptor does not suppress but rather stimulates SRC activity in vivo.
Exposure to death ligands improves the outcome of ex vivo UCB expansion One of the proposed solutions to the relatively low numbers of progenitors in UCB is ex vivo expansion, [13] [14] [15] a process that would be best implemented by induction of proliferation and arrest of progenitor differentiation. Since supportive chemokines induce progenitor differentiation in these extended cultures, 34, 35 we reasoned that differential sensitivity to apoptosis might be useful for depletion of the differentiated progeny. We used a CD34 + expansion protocol based on nicotinamide 28 and supplemented toxic doses of FasL (50 ng/mL) during the third week of culture, the period associated with largest quantitative expansion of cells. Fas cross-linking during the terminal culture period increased the fractions of CD34 + progenitors exceeding the expansion achieved by this protocol (Figure 4a) .
To determine the quality of progenitor exposure to FasL during the expansion culture, cells were assessed in two functional assays. Increased CD34 + fractions following expansion in the presence of FasL might be mediated either by arrest of differentiation or induction of apoptosis in cells generated by spontaneous differentiation. To determine the mechanism of enrichment, the expanded cells were first assayed in semisolidmethylcellulose cultures. Plating of equal number of total expanded cells showed a significant increase in myeloid progenitor activity following exposure to FasL (P o0.01, Figure 4b ), indicative of a net increase in CFU frequency following Fas cross-linking. In a second assay the dead cells were eliminated by centrifugation over a ficoll gradient (Figure 3a) , and equal numbers of viable cells were plated in semisolid cultures (Figure 4b) . Elimination of the dead cells resulted in marked enrichment in CFU-GM frequency under both expanded and FasLsupplemented cultures (P o 0.001), consistent with progenitor enrichment in fresh UCB samples. The proportional enrichment in net numbers and progenitor fractions mediated by FasL suggest that the main mechanism was induction of apoptosis in sensitive cells during terminal stages of the expansion procedure. In the second assay, the quality of expanded progenitors was assessed in xenogeneic transplants in BU-conditioned NOD.SCID mice. Progenitors expanded with and without Fas cross-linking showed comparable levels of engraftment in the bone marrow and spleen after 12 weeks (Figure 4c) , demonstrating that exposure to FasL in terminal stages of expansion did not impair SRC activity.
DISCUSSION
Our findings extend the evidence of insensitivity of UCB-derived hematopoietic progenitors to apoptosis mediated by the Fas and TNF receptors, in addition to resistance to apoptotic signaling mediated by the TRAIL receptors. 19, 20, 22 Resistance of human UCB progenitors to receptor-mediated apoptosis, consistently observed in mobilized-peripheral blood cells 22, 27 and murinebone marrow, [17] [18] [19] 21 evolves as an inherent characteristic of hematopoietic precursors.
20 Furthermore, we demonstrate by direct measurements of viability and functional hematopoieticreconstitution assays that TNF-induced Fas expression in 40% of the CD34 + progenitors does not sensitize to apoptosis induced by receptor cross-linking, similar to observations in murine-bone marrow. 18 Hematopoietic cells progressively acquire sensitivity to receptor-mediated apoptosis in the course of differentiation, which becomes the dominant mechanism of physiologicalnegative regulation of the mature progeny. [18] [19] [20] [21] [22] Differential sensitivities of progenitors and differentiated cells to receptormediated apoptosis can be employed to improve the outcome of UCB transplants.
Negative selection by induction of receptor-mediated apoptosis in mature lineages generates a larger graft than positive selection of progenitors using identifying markers. Considering the infidelity of CD34 as an identifier of hematopoietic progenitors, 36 this approach includes more cells with hematopoietic-reconstituting potential in the graft. In fresh UCB samples, B lymphocytes and myeloid cells are sensitive to spontaneous apoptosis during 24-48 h of incubation and their death increases the percentage of progenitors. Despite insignificant variations in the measured levels of fractional apoptosis, more sensitive functional assays revealed increased-progenitor frequencies. Consistent with application of each one of the death ligands alone, combined exposure to FasL and TNF-α has no detrimental consequences, in contrast to negative effects in chemokine-supplemented cultures 29, 30 that induce cell cycling and differentiation. 34, 35 Both TNF receptors equally contribute to upregulation of Fas in UCB progenitors within several events mediated by receptor crosstalk. 37 Notably, joint exposure to TNF-α and FasL does not result in cumulative enrichment in progenitors, suggesting that nonprogenitor cells share redundant sensitivities to both receptors.
Pretransplant activation of the Fas and TNF receptors in UCB cells is potentially beneficial in overcoming the relative limitations of these grafts. The first drawback is the low absolute number of progenitors in UCB, which are often insufficient to attain threshold-donor inoculum for transplantation in adult recipients. Differential sensitivities of progenitors and differentiated cells to apoptosis were used to increase the yield of an ex vivo expansion protocol, 28 which would be optimally achieved by induced proliferation of uncommitted progenitors and concomitant inhibition of their commitment to differentiate. Application of the apoptotic challenge during the terminal period of culture, associated with the highest rates of active proliferation and numeric expansion, 13 increased substantially the fractions of CD34 + progenitors. This was achieved primarily through induction of receptor-mediated apoptosis in the differentiated progeny, conferring a competitive advantage to expansion of uncommitted progenitors. Expansion was initiated with isolated CD34 + progenitors that are largely insensitive to apoptosis, and spontaneous differentiation during the extended culture caused gradual sensitization to Fas-receptor signaling and consequently negative regulation by apoptosis. [18] [19] [20] [21] [22] It was therefore evident that the dominant mechanism of increased-CFU percentage in fresh-and expanded-UCB cells was owing to the depletion of more differentiated cells, which are largely insignificant and dispensable in the process of hematopoietic reconstitution.
The second relative drawback of UCB grafts is a slower pace of engraftment of primitive progenitors inexperienced in interaction with the bone-marrow stroma. [7] [8] [9] [10] Proposed solutions include direct inoculation of UCB cells into the bone marrow to overcome ineffective UCB cell homing, 12, 38, 39 and increasing the effective number through the combination of several cord units 11, 12 and ex vivo expansion of progenitors. [13] [14] [15] In addition to generation of a progenitor-enriched graft by functional-negative selection (as compared with phenotypic identification), pretransplant exposure to the death ligands enhanced progenitor activity. Qualitative SRC activity in vivo and clonogenic assays of human hematopoietic progenitors in vitro have demonstrated trophic signaling mediated by TRAIL-R1, 19 Fas 20 and TNF-R1. 22 Here we document that joint exposure of progenitors to Fas and TNF-α also enhanced SRC activity promoting the generation of B lymphocytes, which are the first lineage to develop from human progenitors in mouse xenochimeras. Thus, ex vivo exposure of UCB progenitors to death ligands and their combination simultaneously serves two functions: negative selection of progenitors and activation of their function.
A third envisioned feature with the potential to improve the outcome of human hematopoietic-cell engraftment is GvHD prophylaxis. Although GvH reactivity is undetected in UCB xenochimeras and the severity of GvHD is generally reduced in human UCB transplants, it sometimes imposes severe morbidity. [7] [8] [9] [10] 16 We have recently demonstrated that exposure of donor inoculum to an apoptotic challenge in the absence of host-specific sensitization reduces GvHD severity in mice grafted with haploidentical T cells 26 and human mobilized-peripheral blood xenografts. 27 In view of the preserved-engraftment facilitating and graft versus tumor activities of T cells pretreated with death ligands, it remains to be determined whether UCB T cells have reduced-GvH reactivity following functional depletion. T cells in UCB were largely insensitive to receptor-mediated apoptosis, as immature cells [40] [41] [42] with reduced-cytotoxic activity in response to cytokine stimulation in vitro 43 that become sensitive to negative regulation only after activation. [44] [45] [46] Hematopoietic progenitors derived from different sources display variable susceptibility to spontaneous apoptosis and differential responses to activation of the TNF-family receptors. UCB cells are safely maintained in liquid suspensions for 24-48 h, whereas in mobilized-peripheral blood cells similar rates of apoptosis are observed after 4-12 h of incubation. 27 The relatively activated state of mobilized-peripheral blood cells is also recognized in the shorter period required to activate progenitor function by receptor-mediated trophic signals 22 and the remarkable difference in viability of T cells in culture. 27 It is difficult to predict the potential benefit of application of the current approach to overcome the particular limitations of UCB cells, and whether it can reduce the 10-15 day delay in UCB cell engraftment as compared with bone marrow and mobilizedperipheral blood cells. 47, 48 Various approaches to foster engraftment are being considered 48 to reduce the period of neutropenia following UCB transplants, in particular for treatment of malignancies. 47, 49, 50 Enhancing myeloid reconstitution, particularly in early post-transplant stages may reduce the threat of failure of engraftment 51 and alleviate the high incidence of infections during the period of neutropenia. 52 In summary, resistance of UCB-derived hematopoietic progenitors to apoptosis can be harnessed to improve the outcome of transplants. Polarized sensitivities of UCB cells to spontaneous and receptor-mediated apoptosis can be used for graft preparation and enrichment of progenitors by negative selection, with concomitant-progenitor activation and reduction of GvHD severity. These distinct mechanisms are expected to converge and improve the relative drawbacks of UCB grafts.
